Mental health is an important public health issue. National survey data indicate that 48% of the U.S. adult population have reported a psychiatric disorder at some point in their lives and 30% have reported one in the past 12 months. With the changing healthcare environment, 60% of these patients are identified and receive treatment in the primary care setting. Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care -developed to provide the busy primary care physician with practical and timely strategies for screening and treating patients who have psychiatric disorders. It covers -The continually growing number of drugs available for treatment of mental disorders. -An overview of the epidemiology, pathophysiology, presentation, diagnostic criteria, and screening tests for common psychiatric disorders including anxiety disorders, mood disorders, insomnia, somatization disorder, substance use disorder, eating disorders, dementia, and schizophrenia -Treatment algorithms and other step-by-step approaches to direct the physician who is treating patients with mental disorders including drug dosages, schedules, and routes of administration -Basic pharmacology, pharmacokinetics, drug interaction and safety concerns, and practical dosing issues for all classes of drugs used to treat mental disorders -Guidelines for primary care physicians on when to refer patients to psychiatrist colleagues This handbook is the quintessential resource for primary care physicians needing to screen and treat patients with mental disorders. Brief, but informative, this resource includes a glossary, a listing of printed and electronic mental health resources, a bibliography, and an appendix containing selected diagnostic rating scales.
| |||||||||||||||
Book Description
Editorial Reviews
Review
...a concise well-balanced presentation of the essential practical information required by physicians and other health professionals -- Larry Culpepper, M.D., M.P.H., Chairman of Family Medicine,Boston University, Boston, Massachusetts
This is a concise well-balanced presentation of the essential practical information required by physicians and other health professionals to care for patients with psychiatric disorders -- Larry Culpepper, M.D., M.P.H., Chairman of Family Medicine,Boston University, Boston, Massachusetts
This is a concise well-balanced presentation of the essential practical information required by physicians and other health professionals to care for patients with psychiatric disorders -- Larry Culpepper, M.D., M.P.H., Chairman of Family Medicine,Boston University, Boston, Massachusetts
About the Author
Charles B. Nemeroff, M.D., Ph.D., is Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia. Alan F. Schatzberg, M.D., is Professor and Chairman of Psychiatry and Behavioral Sciences at Stanford University School of Medicine in Stanford, California.
Product Details
Would you like to update product info or give feedback on images?
|
More About the Author
Discover books, learn about writers, read author blogs, and more.
Customer Reviews
|
Share your thoughts with other customers:
|
||||||||||||||||||||||
|
Most Helpful Customer Reviews
7 of 7 people found the following review helpful:
1.0 out of 5 stars
This Psychiatry Textbook Brought to You (and Written By) GlaxoSmithKline,
By
This review is from: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care (Paperback)
The New York Times reported today this textbook was ghostwritten by GlaxoSmithKline. It is tainted by Big Pharma influence. Stay away.
2 of 2 people found the following review helpful:
1.0 out of 5 stars
Big Pharma paying Big Bucks to Big Profs.,
By
This review is from: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care (Paperback)
But the drug maker, then known as SmithKline Beecham, actually had much more involvement than the book described, newly disclosed documents show. The grant paid for a writing company to develop the outline and text for the two named authors, the documents show, and then the writing company said it planned to show three drafts directly to the pharmaceutical company for comments and proposed a timeline for the writing company to furnish the doctors and SmithKline with draft text and final page proofs for approval."That doesn't sound unrestricted to me," Dr. Bernard Lo, a medical ethicist and chairman of an Institute of Medicine group that wrote a 2009 report on conflicts of interest, said after reviewing the documents. "That sounds like they have ultimate control." - The New York Times By DUFF WILSON Published: November 29, 2010
Share your thoughts with other customers: Create your own review
|
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
